Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FES PET/CT Imaging in Metastatic or Recurrent Uterine Cancer
NCT05916196Phase 2Recruiting
- Sponsor
- Abramson Cancer Center
- Start
- Apr 2024
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 2 trial of fluoroestradiol f 18 in uterine cancer, sponsored by Abramson Cancer Center. Started Apr 2024; status: recruiting.
02
Drugs
fluoroestradiol f 18
03
Conditions
uterine cancer
Beyond the preview
Go deeper on NCT05916196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05916196.